PROJECT, PROGRAM, & PORTFOLIO RISK ANALYSIS
- Online via Cisco Webex
- October 13-15 | 2021
- 10 am - 3pm EST (UTC-4) / 3 pm - 8pm GMT (EST+1)
MASTERCLASS OVERVIEW
Learn how to quantify and manage risk at project, program, and
portfolio levels. Assess the extent to which multiple indications
and/or lines of therapy affect program risk and valuation. Quantify
the likelihood that your R&D pipeline portfolio and commercial
portfolio will meet annual corporate targets.
AUDIENCE
- Project, Program & Portfolio Management
- Research
- Clinical Development
- Resource Management
- Forecasting & Competitive Intelligence
- Finance
- Licensing & Business Development
STRUCTURE
To maximize learning potential and for easy scheduling, this Online Masterclass has been split up into 3 real-time easy-to-digest 5-hour sessions.
- Session 1: October 13 (10 am - 3pm EST / 3pm - 8pm GMT)
- Session 2: October 14 (10 am - 3pm EST / 3pm - 8pm GMT)
- Session 3: October 15 (10 am - 3pm EST / 3pm - 8pm GMT)
Masterclassleader
Dr. Richard Bayney is President of Project & Portfolio Value Creation (PPVC), a consulting boutique that he founded in 2008 which provides training and education in Project, Program, Portfolio, Resource, and Risk Management as well as Business, Strategic, Portfolio, and Scenario Planning services. He is an adjunct faculty member at the University of Pennsylvania.
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. In his previous position at Johnson & Johnson, Richard was Vice President, Portfolio Management & Decision Analysis. Dr. Bayney obtained his M.Sc. and Ph.D. from the University of London, MBA from Columbia University, and PMP from the Project Management Institute.
Features
REAL-TIME &INSTRUCTOR-LED
REAL-TIME
LIVE DISCUSSIONSINTERACTIVE POLLING
INTERACTION
CONTENT-PACKED &CERTIFIED
CERTIFIED
TOPIC SNEAK PEEK
- Quantification of project risk using risk decomposition and Decision Trees
- Quantification of program risk using correlated project risks and Decision Trees
- Quantification of portfolio risk using simulation
- Generation of strategic alternatives for Clinical Development, Registration, and Commercialization
- Selecting dominant strategies based on eNPV
- Accounting for commercial uncertainty in the product portfolio using simulation
- Accounting for risk and commercial uncertainty in the pipeline portfolio
- Quantifying the likelihood of meeting corporate growth targets (Long Range Plan)
REGISTRATION
masterclass
Online Ticket (EUR)-
Access to the 3 Part Real-time Instructor Lead Masterclass
-
Networking with Attendees
-
Case Studies & Activities
-
Colored Hardcopy of Training Materials
-
Electronic Copy of Trainer's Textbook
-
Certificate of Completion issued by Trainer